Plato Gold Corp. has completed a non-brokered flow-through private placement, raising $55,000 by issuing 1.1 million shares at $0.05 each. The funds will support exploration expenses at its Pic River Platinum Group Metals Project in Ontario, with expenditures to be incurred and renounced by the end of 2026. The offering was originally up to $150,000 but was terminated after this tranche. The shares are subject to a hold period until January 30, 2027, and the transaction included participation by the company's CEO, Anthony Cohen.
Plato Gold Corp.'s recent private placement is noted here alongside Basic Materials sector data from Pluang. For readers following Basic Materials, here is Pluang's market snapshot as of Nov 03, 2026 05:02 WIB: Out of 83 priced US stocks, 55 rose and 27 fell. Notable movers include EXK (Endeavour Silver Corp) at USD 7.22 with a 1-day change of -6.96% and typical hold time of 28 days, CRH (CRH PLC Ordinary Shares) at USD 96.69 up 6.43% with a 9-day hold, and GFI (Gold Fields Limited) at USD 35.00 rising 6.32% with a 51-day hold and a sell-heavy order activity of 88% sell to 12% buy.
The Geely E2 (EX2) electric car has reached one million units sold globally within two years of its launch in October 2024, marking rapid market acceptance. It became the world's best-selling car in A&B segments in 2025 and topped sales charts in cou...
AI data centers are expanding beyond traditional land-based locations due to increasing power and space constraints. Companies like Aikido Technologies are exploring floating data centers powered by offshore wind, while Elon Musk's SpaceX plans to de...
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
